SCHEMBL8554953

SCHEMBL8554953

O=C(O)Cn1c(=O)c(=O)[nH]c2cc(Cl)c(Cl)c([N+](=O)[O-])c21

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 12/20 0.56
GRIN3B O60391 12/20 0.56
GRIN1 Q05586 12/20 0.56
GRIN2A Q12879 12/20 0.56
GRIN2B Q13224 12/20 0.56
GRIN2C Q14957 12/20 0.56
GRIN3A Q8TCU5 12/20 0.56
GRIA1 P42261 6/20 0.56
GRIA2 P42262 6/20 0.56
GRIA3 P42263 6/20 0.56
GRIA4 P48058 6/20 0.56
GRIK1 P39086 5/20 0.47
GRIK2 Q13002 5/20 0.47
GRIK5 Q16478 5/20 0.47
GRIK3 Q13003 4/20 0.47
GRIK4 Q16099 3/20 0.47
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902355 0.81 GRIA1 (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8903169 0.81 GRIA1 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8556002 0.80 GRIN1 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL11928973 0.77 GRIN2D (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8556947 0.76 GRIN2D (0.62) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL10281565 0.75 GRIN2D (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8612021 0.75 GRIA1 (0.72) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8558856 0.74 GRIA1 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7787811 0.74 GRIA1 (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8618891 0.73 GRIK1 (0.57) GRIA1GRIA2GRIA3GRIA4GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647137-A4 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF. UNIV CALIFORNIA WEBER ECKARD (US) 1998-09-16 EP disclosed
US-5622952-A NERVOUS SYSTEM DISORDERS; ADMINISTERING 1,4-DIHYDROQUINOXALINE-2,3-DIONE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-22 US disclosed
US-5620979-A TREATING NEURONAL LOSS ASSOCIATED WITH STROKE, ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA OR SURGERY STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-15 US disclosed
US-5514680-A ANTICONVULSANTS WITH 5,6,7-TRISUBSTITUTED-1,4-DIHYDROQUINOXALINE-2,3-DIONE THE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) 1996-05-07 US disclosed
EP-0647137-A1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-04-12 EP disclosed
WO-1994000124-A1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF WEBER ECKARD (US) 1994-01-06 WO disclosed